OA03630A - Process for the preparation of a new family of compounds with antispasmodic, antiarrhythmic, antipyretic and antimalarial activity. - Google Patents

Process for the preparation of a new family of compounds with antispasmodic, antiarrhythmic, antipyretic and antimalarial activity.

Info

Publication number
OA03630A
OA03630A OA53676A OA53676A OA03630A OA 03630 A OA03630 A OA 03630A OA 53676 A OA53676 A OA 53676A OA 53676 A OA53676 A OA 53676A OA 03630 A OA03630 A OA 03630A
Authority
OA
OAPI
Prior art keywords
antispasmodic
antiarrhythmic
antipyretic
compounds
preparation
Prior art date
Application number
OA53676A
Other languages
French (fr)
Original Assignee
Sogeras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sogeras filed Critical Sogeras
Publication of OA03630A publication Critical patent/OA03630A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
OA53676A 1968-07-18 1969-07-18 Process for the preparation of a new family of compounds with antispasmodic, antiarrhythmic, antipyretic and antimalarial activity. OA03630A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3438268 1968-07-18

Publications (1)

Publication Number Publication Date
OA03630A true OA03630A (en) 1971-12-24

Family

ID=10364956

Family Applications (1)

Application Number Title Priority Date Filing Date
OA53676A OA03630A (en) 1968-07-18 1969-07-18 Process for the preparation of a new family of compounds with antispasmodic, antiarrhythmic, antipyretic and antimalarial activity.

Country Status (8)

Country Link
BE (1) BE735129A (en)
CH (1) CH502386A (en)
DE (1) DE1936723C2 (en)
ES (1) ES369337A1 (en)
FR (1) FR2013170A1 (en)
GB (1) GB1227830A (en)
NL (1) NL149808B (en)
OA (1) OA03630A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1294538A (en) * 1970-04-30 1972-11-01 Rech S Et D Applic Scient Soge Pharmaceutical compositions
FR2201898A1 (en) * 1973-05-30 1974-05-03 Sogeras Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
EP0676206B1 (en) * 1993-09-20 2000-01-05 Ajinomoto Co., Inc. Antimalarial
ES2121627T3 (en) * 1994-06-10 1998-12-01 Dumex Ltd As MEDICINAL SALTS.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1143204B (en) * 1958-08-05 1963-02-07 Mundipharma Ag Process for the preparation of quinidine galacturonate and quinidine polygalacturonate
DE1218457B (en) * 1961-10-10 1966-06-08 Mundipharma Ag Process for the preparation of dihydroquinidine galacturonate and dihydroquinidine polygalacturonate

Also Published As

Publication number Publication date
BE735129A (en) 1969-12-01
DE1936723A1 (en) 1970-05-14
CH502386A (en) 1971-01-31
NL149808B (en) 1976-06-15
FR2013170A1 (en) 1970-03-27
NL6910987A (en) 1970-01-20
GB1227830A (en) 1971-04-07
DE1936723C2 (en) 1983-12-22
ES369337A1 (en) 1971-06-01

Similar Documents

Publication Publication Date Title
OA03859A (en) Process for the production of compounds with pharmaceutical activity.
FR2317912A1 (en) NEW PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION, ACTING ON THE CENTRAL NERVOUS SYSTEM
OA04093A (en) Process for the preparation of ortho-disubstituted aryl-guanidines.
CH537978A (en) Process for preparing a beer wort, and wort resulting from the process
OA03630A (en) Process for the preparation of a new family of compounds with antispasmodic, antiarrhythmic, antipyretic and antimalarial activity.
FR1448790A (en) Process for the preparation of alpha-monochloro-nu, nu-dialkoyl-aceto-acetamides
OA03864A (en) Process for the preparation of a medicament based on pyridoxine P-chlophenoxyisobutyrate.
OA04784A (en) New process for the preparation of 2,5 disubstituted benzamides.
FR1533178A (en) Process for the preparation of crosslinked synthetic resins based on polyhydroxy compounds, polyisocyanates and chain extenders
FR1504480A (en) Improvement relating to a process for the preparation of 1, 2-dichloroethane
CH433162A (en) Process for the preparation of a stable high activity lipase
CH502123A (en) Process for the preparation of a mixed catalyst
CH556327A (en) PROCESS FOR THE PREPARATION OF A DECAPEPTIDE.
OA00939A (en) Process for the preparation of amino-isoxazoles.
FR2274337A1 (en) LINING ELEMENTS, ESPECIALLY FOR DISTILLATION AND ABSORPTION COLUMNS
OA04266A (en) Process and device for the preparation of carbonaceous pastes intended for the manufacture of electrodes.
CH525854A (en) Process for the preparation of a p-nitrophenol
CH553738A (en) PROCESS FOR THE PREPARATION OF A DIALCOYLACETAL DU (BETA), (DELTA) -DIOXOENANTHALDEHYDE.
OA04265A (en) Process for obtaining uranium compounds.
FR1373390A (en) Tedding machine, specially designed for forming swaths
NO136195C (en) PROCEDURES FOR THE PREPARATION OF 2,4-DIAMINO-5-BENZYLPYRIMIDINES.
DK130967B (en) Analogous process for the preparation of 2- (3,4-dichloroaniline) -quinolizine bromide.
BE792330A (en) PROCEDURE FOR PREVENTING RESINS FROM ADHESING TO A
FR1469485A (en) Process for the preparation of a new series of schiff bases
CH428722A (en) Process for the preparation of a 16α-ethynyl-19-nor-1,3,5 (10) -androstatriene